T-ALL is characterized by dysregulation of critical signaling pathways, including NOTCH1, PI3K/AKT/mTOR, and JAK/STAT, which play pivotal roles in T-cell development and leukemogenesis. Here, AKT1 is linked to acute lymphoblastic leukemia.